Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia

Hemophilia Inhibitor Previously Untreated Patient Study

NCT01652027 ·Status: COMPLETED

Inhibitor Development in Patients With Hemophilia A Undergoing Surgery

NCT01571934 ·Status: COMPLETED

Use of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIa

NCT01856751 ·Status: UNKNOWN

A Study Comparing Factor Level and Inhibitor Titer Testing Results Drawn From Central Venous Lines and Venipuncture

NCT02402829 ·Status: TERMINATED

Phenotypic Heterogeneity in Hemophilia A: An Investigation of the Role of Platelet Function

NCT02225483 ·Status: COMPLETED

Platelet Function in Patients With Hemophilia A

NCT02093065 ·Status: COMPLETED

Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients

NCT01712438 ·Status: COMPLETED ·Phase: PHASE3

Activity and Content of Factor VIII (FVIII) in Human Plasma: The Assessment of a Novel Immunoassay

NCT00839202 ·Status: COMPLETED ·Phase: NA

The Dynamic Interplay Between Bleeding Phenotype and Baseline Factor Level in Moderate and Mild Hemophilia A and B

NCT03623295 ·Status: COMPLETED

Acquired Hemophilia A and Autoimmunity. Study of Lymphocyte Populations and Myeloid-Derived Suppressor Cells

NCT04805021 ·Status: RECRUITING

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917 ·Status: COMPLETED ·Phase: PHASE3

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

NCT03876301 ·Status: COMPLETED

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

NCT00306670 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Long-term Anticoagulation in a Patient With Severe Hemophilia A

NCT07314983 ·Status: RECRUITING

Clot Formation and Clot Stability in Patients With Severe Haemophilia A

NCT00279578 ·Status: COMPLETED ·Phase: NA

Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

NCT00782470 ·Status: COMPLETED

Inter Individual Variability in Initiation Pathway Activation and Regulation and Phenotypic Heterogeneity in Patients With Haemophilia A and B

NCT03287999 ·Status: UNKNOWN

Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A

NCT02697370 ·Status: COMPLETED ·Phase: PHASE4

Health Related Quality of Life of Youth and Young Adults With Hemophilia A

NCT01034904 ·Status: COMPLETED

Improved Factor VIII Inhibitor Evaluation

NCT02726139 ·Status: WITHDRAWN

A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Protein for Injection

NCT05251090 ·Status: COMPLETED ·Phase: PHASE1

Prophylaxis Versus on Demand Treatment for Children With Hemophilia A

NCT01810666 ·Status: COMPLETED ·Phase: PHASE4

Tissue Factor Pathway Inhibitor (TFPI) and Haemorrhagic Manifestations in Haemophilia A and B Patients

NCT02540187 ·Status: COMPLETED

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

NCT01051544 ·Status: WITHDRAWN ·Phase: NA

Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A

NCT01027377 ·Status: COMPLETED ·Phase: PHASE1